AB Science S.A. (ABSCF)

AB Science S.A. (ABSCF) — VMCI valuation read

The headline on AB Science S.A. (ABSCF) is a 35/100 VMCI score, set against a Healthcare sector median of 50. That 15-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

ABSCF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** ABSCF trades at 25.0x earnings, 39% above the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 2.3x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on ABSCF.

ABSCF fell 2.2% over the trailing 7 days, with a -18.4% read on a 30-day basis.